QuSAGE analysis of GTRD TFT gene sets highlighted numerous transcription factors whose downstream targets were differentially expressed in tumors with high ColX module expression, several of which are known to modulate tumor advantage in breast or pancreatic cancer (Fig. 3C; see Table S5B for detailed descriptions of significant TFs). The gene discussed is TBXT; the disease is pancreatic neoplasm.